Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377013757> ?p ?o ?g. }
- W4377013757 endingPage "2073" @default.
- W4377013757 startingPage "2061" @default.
- W4377013757 abstract "Abstract Aims Transforming growth factor-beta (TGF-β) exists in three isoforms TGF-β1, -β2, and -β3. TGF-β1 has been suggested to be important for maintaining plaque stability, yet the role of TGF-β2 and -β3 in atherosclerosis remains to be investigated. This study explores the association of the three isoforms of TGF-β with plaque stability in the human atherosclerotic disease. Methods and results TGF-β1, -β2, and -β3 proteins were quantified in 223 human carotid plaques by immunoassays. Indications for the endarterectomy were: symptomatic carotid plaque with stenosis >70% or without symptoms and >80% stenosis. Plaque mRNA levels were assessed by RNA sequencing. Plaque components and extracellular matrix were measured histologically and biochemically. Matrix metalloproteinases and monocyte chemoattractant protein-1 (MCP-1) was measured with immunoassays. The effect of TGF-β2 on inflammation and protease activity was investigated in vitro using THP-1 and RAW264.7 macrophages. Patients were followed longitudinally for cardiovascular (CV) events. TGF-β2 was the most abundant isoform and was increased at both protein and mRNA levels in asymptomatic plaques. TGF-β2 was the main determinant separating asymptomatic plaques in an Orthogonal Projections to Latent Structures Discriminant Analysis. TGF-β2 correlated positively to features of plaque stability and inversely to markers of plaque vulnerability. TGF-β2 was the only isoform inversely correlated to the matrix-degrading matrix metalloproteinase-9 and inflammation in the plaque tissue. In vitro, TGF-β2 pre-treatment reduced MCP-1 gene and protein levels as well as matrix metalloproteinase-9 gene levels and activity. Patients with plaques with high TGF-β2 levels had a lower risk to suffer from future CV events. Conclusions TGF-β2 is the most abundant TGF-β isoform in human plaques and may maintain plaque stability by decreasing inflammation and matrix degradation." @default.
- W4377013757 created "2023-05-19" @default.
- W4377013757 creator A5004838021 @default.
- W4377013757 creator A5004935343 @default.
- W4377013757 creator A5012427098 @default.
- W4377013757 creator A5031090226 @default.
- W4377013757 creator A5034805420 @default.
- W4377013757 creator A5035063284 @default.
- W4377013757 creator A5047261292 @default.
- W4377013757 creator A5047837185 @default.
- W4377013757 creator A5048311287 @default.
- W4377013757 creator A5053799285 @default.
- W4377013757 creator A5061315819 @default.
- W4377013757 creator A5077037910 @default.
- W4377013757 creator A5080011836 @default.
- W4377013757 creator A5083755367 @default.
- W4377013757 date "2023-05-18" @default.
- W4377013757 modified "2023-10-18" @default.
- W4377013757 title "Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events" @default.
- W4377013757 cites W100168059 @default.
- W4377013757 cites W1270005002 @default.
- W4377013757 cites W1963968515 @default.
- W4377013757 cites W1969756799 @default.
- W4377013757 cites W1971886602 @default.
- W4377013757 cites W1975451889 @default.
- W4377013757 cites W1979358608 @default.
- W4377013757 cites W1992234633 @default.
- W4377013757 cites W1992410941 @default.
- W4377013757 cites W1993966022 @default.
- W4377013757 cites W2010710364 @default.
- W4377013757 cites W2024160852 @default.
- W4377013757 cites W2033733529 @default.
- W4377013757 cites W2034381554 @default.
- W4377013757 cites W2035704867 @default.
- W4377013757 cites W2052544509 @default.
- W4377013757 cites W2054753294 @default.
- W4377013757 cites W2075181613 @default.
- W4377013757 cites W2096384326 @default.
- W4377013757 cites W2101314011 @default.
- W4377013757 cites W2101426425 @default.
- W4377013757 cites W2111247788 @default.
- W4377013757 cites W2111434189 @default.
- W4377013757 cites W2112360098 @default.
- W4377013757 cites W2119210523 @default.
- W4377013757 cites W2122982115 @default.
- W4377013757 cites W2134917726 @default.
- W4377013757 cites W2136819827 @default.
- W4377013757 cites W2149032061 @default.
- W4377013757 cites W2157280773 @default.
- W4377013757 cites W2164807534 @default.
- W4377013757 cites W2164925121 @default.
- W4377013757 cites W2166018731 @default.
- W4377013757 cites W2168915058 @default.
- W4377013757 cites W2179438025 @default.
- W4377013757 cites W232770196 @default.
- W4377013757 cites W2347012456 @default.
- W4377013757 cites W2510559027 @default.
- W4377013757 cites W2516260084 @default.
- W4377013757 cites W2562263908 @default.
- W4377013757 cites W2604525420 @default.
- W4377013757 cites W2762467945 @default.
- W4377013757 cites W2791004319 @default.
- W4377013757 cites W2794080343 @default.
- W4377013757 cites W2896758442 @default.
- W4377013757 cites W3186609176 @default.
- W4377013757 cites W4206582106 @default.
- W4377013757 cites W4240900378 @default.
- W4377013757 doi "https://doi.org/10.1093/cvr/cvad079" @default.
- W4377013757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37200403" @default.
- W4377013757 hasPublicationYear "2023" @default.
- W4377013757 type Work @default.
- W4377013757 citedByCount "1" @default.
- W4377013757 countsByYear W43770137572023 @default.
- W4377013757 crossrefType "journal-article" @default.
- W4377013757 hasAuthorship W4377013757A5004838021 @default.
- W4377013757 hasAuthorship W4377013757A5004935343 @default.
- W4377013757 hasAuthorship W4377013757A5012427098 @default.
- W4377013757 hasAuthorship W4377013757A5031090226 @default.
- W4377013757 hasAuthorship W4377013757A5034805420 @default.
- W4377013757 hasAuthorship W4377013757A5035063284 @default.
- W4377013757 hasAuthorship W4377013757A5047261292 @default.
- W4377013757 hasAuthorship W4377013757A5047837185 @default.
- W4377013757 hasAuthorship W4377013757A5048311287 @default.
- W4377013757 hasAuthorship W4377013757A5053799285 @default.
- W4377013757 hasAuthorship W4377013757A5061315819 @default.
- W4377013757 hasAuthorship W4377013757A5077037910 @default.
- W4377013757 hasAuthorship W4377013757A5080011836 @default.
- W4377013757 hasAuthorship W4377013757A5083755367 @default.
- W4377013757 hasBestOaLocation W43770137571 @default.
- W4377013757 hasConcept C104317684 @default.
- W4377013757 hasConcept C118131993 @default.
- W4377013757 hasConcept C126322002 @default.
- W4377013757 hasConcept C134018914 @default.
- W4377013757 hasConcept C142724271 @default.
- W4377013757 hasConcept C189165786 @default.
- W4377013757 hasConcept C2776914184 @default.
- W4377013757 hasConcept C2778229498 @default.
- W4377013757 hasConcept C2778710248 @default.